EU regulator not updating opinion on Eisai-Biogen's Alzheimer's drug
European Union's human medicines committee (CHMP) said on Friday it is not updating its opinion on Eisai and Biogen's ...
Hosted on MSN6h
Two drugs prove to be effective against Alzheimer's disease in new study
A new study has shown that two drugs - lecanemab and donanemab - could help patients stay independent by approximately 10–13 ...
FiercePharma18h
Eisai to part ways with 121 employees amid new US restructuring effort
Amid Eisai’s efforts to capitalize on a potential growth surge for its Alzheimer’s disease med Leqembi, the Japanese ...
Seizures Pipeline Insight Analysis Report, Competitive Analysis of Eisai, Novartis, Johnson & Johnson, and Neurelis
The "Seizures Pipeline Insight Analysis Report" drug pipelines has been added to ResearchAndMarkets.com's offering.The Seizures treatment pipeline analysis provides an overview of recent advancements ...